CFDE Data Portal | Search LINC02983

	Label	Description
	LINC02983 Gene (Entity type)	ENSG00000234432 - long intergenic non-protein coding RNA 2983
	GSE128076 doxycycline HEK293 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE143782 calcitriol 3 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE258991 enzalutamide DK1 [Tursiops] 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE146982 metformin 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE189035 inositol 2 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE155162 GSE155169 buparlisib 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE119978 GSE180930 cisplatin 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE173201 cisplatin 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE128076 doxycycline HEK293 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS

LINC02983

ENSG00000234432 - long intergenic non-protein coding RNA 2983

GSE128076 doxycycline HEK293 1 v 3 human dn

A Gene Set from LINCS

GSE143782 calcitriol 3 v 4 human up

A Gene Set from LINCS

GSE258991 enzalutamide DK1 [Tursiops] 1 v 0 human up

A Gene Set from LINCS

GSE146982 metformin 0 v 1 human dn

A Gene Set from LINCS

GSE189035 inositol 2 v 4 human up

A Gene Set from LINCS

GSE155162 GSE155169 buparlisib 1 v 3 human up

A Gene Set from LINCS

GSE119978 GSE180930 cisplatin 2 v 1 human dn

A Gene Set from LINCS

GSE173201 cisplatin 2 v 3 human up

A Gene Set from LINCS

GSE128076 doxycycline HEK293 1 v 0 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.